| 1 | [SID49679332] | Active | AbsAC35_uM | 4.03 | Counterscreen for inhibitors of NLG for Luciferase Activators Measured in Cell-Based System Using Plate Reader - 2146-03_Inhibitor_Dose_CherryPick_Activity [AID624404, Type: confirmatory] | |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 49679332 | | CID | 45105751 | | Outcome | Active | | AbsAC35_uM | 4.03 [uM] | | BioAssay | Counterscreen for inhibitors of NLG for Luciferase Activators Measured in Cell-Based System Using Plate Reader - 2146-03_Inhibitor_Dose_CherryPick_Activity | | AID | 624404 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 2 | [SID49679332] | Active | AbsAC26_uM | 4.28 | Luciferase Reporter Cell Based HTS to identify inhibitors of N-linked Glycosylation Measured in Cell-Based System Using Plate Reader - 2146-01_Inhibitor_Dose_CherryPick_Activity [AID624491, Type: confirmatory] | |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 49679332 | | CID | 45105751 | | Outcome | Active | | AbsAC26_uM | 4.28 [uM] | | BioAssay | Luciferase Reporter Cell Based HTS to identify inhibitors of N-linked Glycosylation Measured in Cell-Based System Using Plate Reader - 2146-01_Inhibitor_Dose_CherryPick_Activity | | AID | 624491 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 3 | [SID49679332] | Active | Potency | 4.6109 | Nrf2 qHTS screen for inhibitors [AID504444, Type: confirmatory] | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 49679332 | | CID | 45105751 | | Outcome | Active | | Potency | 4.6109 [uM] | | BioAssay | Nrf2 qHTS screen for inhibitors | | AID | 504444 | | BioAssay type | confirmatory | | Target | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] | | PubMed | | | Data Table |  |
|
| 4 | [SID49679332] | Active | Potency | 4.6109 | Nrf2 qHTS screen for inhibitors [AID504444, Type: confirmatory] | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 49679332 | | CID | 45105751 | | Outcome | Active | | Potency | 4.6109 [uM] | | BioAssay | Nrf2 qHTS screen for inhibitors | | AID | 504444 | | BioAssay type | confirmatory | | Target | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] | | PubMed | | | Data Table |  |
|
| 5 | [SID49679332] | Active | Potency | 4.6109 | Nrf2 qHTS screen for inhibitors [AID504444, Type: confirmatory] | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 49679332 | | CID | 45105751 | | Outcome | Active | | Potency | 4.6109 [uM] | | BioAssay | Nrf2 qHTS screen for inhibitors | | AID | 504444 | | BioAssay type | confirmatory | | Target | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] | | PubMed | | | Data Table |  |
|
| 6 | [SID49679332] | Active | Potency | 4.6109 | Nrf2 qHTS screen for inhibitors [AID504444, Type: confirmatory] | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 49679332 | | CID | 45105751 | | Outcome | Active | | Potency | 4.6109 [uM] | | BioAssay | Nrf2 qHTS screen for inhibitors | | AID | 504444 | | BioAssay type | confirmatory | | Target | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] | | PubMed | | | Data Table |  |
|
| 7 | [SID49679332] | Active | EC50 | 8.769 | Luminescence Cell-Based Dose Confimation HTS to Identify Inhibitors of of 5'UTR Stem-Loop Driven Alpha-Synuclein mRNA Translation in H4 Neuroglioblastoma Cells [AID1988, Type: confirmatory] | |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 49679332 | | CID | 45105751 | | Outcome | Active | | EC50 | 8.769 [uM] | | BioAssay | Luminescence Cell-Based Dose Confimation HTS to Identify Inhibitors of of 5'UTR Stem-Loop Driven Alpha-Synuclein mRNA Translation in H4 Neuroglioblastoma Cells | | AID | 1988 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 8 | [SID49679332] | Active | EC50 | 11.212 | Luminescence Cell-Based Dose Response HTS to Identify Inhibitors of Luciferase Translation or Activity in H4 Neuroglioblastoma Cells [AID1990, Type: confirmatory] | |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 49679332 | | CID | 45105751 | | Outcome | Active | | EC50 | 11.212 [uM] | | BioAssay | Luminescence Cell-Based Dose Response HTS to Identify Inhibitors of Luciferase Translation or Activity in H4 Neuroglioblastoma Cells | | AID | 1990 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 9 | [SID49679332] | Active | EC50 | 11.885 | Luminescence Cell-Based Dose Response HTS to Identify Inhibitors of 5'UTR Stem-Loop Driven Prion Protein mRNA Translation in H4 Neuroglioblastoma Cells [AID1994, Type: confirmatory] | |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 49679332 | | CID | 45105751 | | Outcome | Active | | EC50 | 11.885 [uM] | | BioAssay | Luminescence Cell-Based Dose Response HTS to Identify Inhibitors of 5'UTR Stem-Loop Driven Prion Protein mRNA Translation in H4 Neuroglioblastoma Cells | | AID | 1994 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 10 | [SID49679332] | Active | CC50 | 12.89 | An HTS Cytotoxicity Screen to evaluate New Inhibitors of Respiratory Syncytial Virus (RSV) [AID2410, Type: confirmatory] | |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 49679332 | | CID | 45105751 | | Outcome | Active | | CC50 | 12.89 [uM] | | BioAssay | An HTS Cytotoxicity Screen to evaluate New Inhibitors of Respiratory Syncytial Virus (RSV) | | AID | 2410 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 11 | [SID49679332] | Active | Potency | 16.3601 | A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells. [AID624296, Type: confirmatory] | GMNN gene product [Homo sapiens] [gi:7705682] |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 49679332 | | CID | 45105751 | | Outcome | Active | | Potency | 16.3601 [uM] | | BioAssay | A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells. | | AID | 624296 | | BioAssay type | confirmatory | | Target | GMNN gene product [Homo sapiens] [gi:7705682] | | PubMed | | | Data Table |  |
|
| 12 | [SID49679332] | Active | CC50 | 31.99 | A Cell Based Secondary Assay To Explore Cytotoxicity of West Nile Virus Anti-Viral Hit Compounds [AID1650, Type: confirmatory] | |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 49679332 | | CID | 45105751 | | Outcome | Active | | CC50 | 31.99 [uM] | | BioAssay | A Cell Based Secondary Assay To Explore Cytotoxicity of West Nile Virus Anti-Viral Hit Compounds | | AID | 1650 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 13 | [SID49679332] | Active | | | MLPCN Alpha-Synuclein 5'UTR - 5'-UTR binding - inhibitors [AID1813, Type: screening] | |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 49679332 | | CID | 45105751 | | Outcome | Active | | BioAssay | MLPCN Alpha-Synuclein 5'UTR - 5'-UTR binding - inhibitors | | AID | 1813 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 14 | [SID49679332] | Active | | | Luciferase Reporter Cell Based HTS to identify inhibitors of N-linked Glycosylation Measured in Cell-Based System Using Plate Reader - 2146-01_Inhibitor_SinglePoint_HTS_Activity_Set2 [AID588692, Type: screening] | |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 49679332 | | CID | 45105751 | | Outcome | Active | | BioAssay | Luciferase Reporter Cell Based HTS to identify inhibitors of N-linked Glycosylation Measured in Cell-Based System Using Plate Reader - 2146-01_Inhibitor_SinglePoint_HTS_Activity_Set2 | | AID | 588692 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 15 | [SID49679332] | Active | | | Counterscreen for agonists of OPRM1-OPRD1 heterodimerization: luminescence-based cell-based full-deck high throughput screening assay to identify agonists of 5-hydroxytryptamine (serotonin) 5A receptor (HTR5A) [AID504692, Type: screening] | HTR5A gene product [Homo sapiens] [gi:13236497] |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 49679332 | | CID | 45105751 | | Outcome | Active | | BioAssay | Counterscreen for agonists of OPRM1-OPRD1 heterodimerization: luminescence-based cell-based full-deck high throughput screening assay to identify agonists of 5-hydroxytryptamine (serotonin) 5A receptor (HTR5A) | | AID | 504692 | | BioAssay type | screening | | Target | HTR5A gene product [Homo sapiens] [gi:13236497] | | PubMed | | | Data Table |  |
|
| 16 | [SID49679332] | Active | | | Counterscreen for agonists of OPRM1-OPRD1 heterodimerization: luminescence-based cell-based full-deck high throughput screening assay to identify agonists of 5-hydroxytryptamine (serotonin) 5A receptor (HTR5A) [AID504692, Type: screening] | HTR5A gene product [Homo sapiens] [gi:13236497] |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 49679332 | | CID | 45105751 | | Outcome | Active | | BioAssay | Counterscreen for agonists of OPRM1-OPRD1 heterodimerization: luminescence-based cell-based full-deck high throughput screening assay to identify agonists of 5-hydroxytryptamine (serotonin) 5A receptor (HTR5A) | | AID | 504692 | | BioAssay type | screening | | Target | HTR5A gene product [Homo sapiens] [gi:13236497] | | PubMed | | | Data Table |  |
|
| 17 | [SID49679332] | Active | | | Counterscreen for agonists of OPRM1-OPRD1 heterodimerization: luminescence-based cell-based full-deck high throughput screening assay to identify agonists of 5-hydroxytryptamine (serotonin) 5A receptor (HTR5A) [AID504692, Type: screening] | HTR5A gene product [Homo sapiens] [gi:13236497] |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 49679332 | | CID | 45105751 | | Outcome | Active | | BioAssay | Counterscreen for agonists of OPRM1-OPRD1 heterodimerization: luminescence-based cell-based full-deck high throughput screening assay to identify agonists of 5-hydroxytryptamine (serotonin) 5A receptor (HTR5A) | | AID | 504692 | | BioAssay type | screening | | Target | HTR5A gene product [Homo sapiens] [gi:13236497] | | PubMed | | | Data Table |  |
|
| 18 | [SID49679332] | Active | | | HTS Assay for Peg3 Promoter Inhibitors [AID588405, Type: screening] | Ppp1r15a gene product [Rattus norvegicus] [gi:78486550] |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 49679332 | | CID | 45105751 | | Outcome | Active | | BioAssay | HTS Assay for Peg3 Promoter Inhibitors | | AID | 588405 | | BioAssay type | screening | | Target | Ppp1r15a gene product [Rattus norvegicus] [gi:78486550] | | PubMed | | | Data Table |  |
|
| 19 | [SID49679332] | Active | | | Luminescence-based cell-based primary high throughput screening assay to identify agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors [AID504326, Type: screening] | OPRD1 gene product [Homo sapiens] [gi:63477962] |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 49679332 | | CID | 45105751 | | Outcome | Active | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors | | AID | 504326 | | BioAssay type | screening | | Target | OPRD1 gene product [Homo sapiens] [gi:63477962] | | PubMed | | | Data Table |  |
|
| 20 | [SID49679332] | Active | | | Luminescence-based cell-based primary high throughput screening assay to identify agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors [AID504326, Type: screening] | OPRD1 gene product [Homo sapiens] [gi:63477962] |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 49679332 | | CID | 45105751 | | Outcome | Active | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors | | AID | 504326 | | BioAssay type | screening | | Target | OPRD1 gene product [Homo sapiens] [gi:63477962] | | PubMed | | | Data Table |  |
|
| 21 | [SID49679332] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 49679332 | | CID | 45105751 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 22 | [SID49679332] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 49679332 | | CID | 45105751 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 23 | [SID49679332] | Inactive | Potency | 4.1475 | Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation [AID504834, Type: confirmatory] | |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 49679332 | | CID | 45105751 | | Outcome | Inactive | | Potency | 4.1475 [uM] | | BioAssay | Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation | | AID | 504834 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 24 | [SID49679332] | Inactive | Potency | 7.0795 | qHTS for Inhibitors of TGF-b: Cytotox Counterscreen [AID588856, Type: confirmatory] | |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 49679332 | | CID | 45105751 | | Outcome | Inactive | | Potency | 7.0795 [uM] | | BioAssay | qHTS for Inhibitors of TGF-b: Cytotox Counterscreen | | AID | 588856 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 25 | [SID49679332] | Inactive | Potency | 31.6228 | qHTS Inhibitors of AmpC Beta-Lactamase (assay without detergent) [AID485341, Type: confirmatory] | Chain A, Ampc Beta-Lactamase In Complex With 4-Methanesulfonylamino Benzoic Acid [gi:119389684] |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 49679332 | | CID | 45105751 | | Outcome | Inactive | | Potency | 31.6228 [uM] | | BioAssay | qHTS Inhibitors of AmpC Beta-Lactamase (assay without detergent) | | AID | 485341 | | BioAssay type | confirmatory | | Target | Chain A, Ampc Beta-Lactamase In Complex With 4-Methanesulfonylamino Benzoic Acid [gi:119389684] | | PubMed | | | Data Table |  |
|
| 26 | [SID49679332] | Inactive | Potency | | qHTS Inhibitors of AmpC Beta-Lactamase (assay with detergent) [AID485294, Type: confirmatory] | Chain A, Ampc Beta-Lactamase In Complex With 4-Methanesulfonylamino Benzoic Acid [gi:119389684] |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 49679332 | | CID | 45105751 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Inhibitors of AmpC Beta-Lactamase (assay with detergent) | | AID | 485294 | | BioAssay type | confirmatory | | Target | Chain A, Ampc Beta-Lactamase In Complex With 4-Methanesulfonylamino Benzoic Acid [gi:119389684] | | PubMed | | | Data Table |  |
|
| 27 | [SID49679332] | Inactive | | | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the HTRA serine peptidase 1 (HTRA1) [AID504803, Type: screening] | HTRA1 protein [gi:121945198] |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 49679332 | | CID | 45105751 | | Outcome | Inactive | | BioAssay | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the HTRA serine peptidase 1 (HTRA1) | | AID | 504803 | | BioAssay type | screening | | Target | HTRA1 protein [gi:121945198] | | PubMed | | | Data Table |  |
|
| 28 | [SID49679332] | Inactive | Potency | | qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia [AID2451, Type: confirmatory] | Chain A, Structure Of Giardia Fructose-1,6-Biphosphate Aldolase In Complex With Phosphoglycolohydrox [gi:122920737] |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 49679332 | | CID | 45105751 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia | | AID | 2451 | | BioAssay type | confirmatory | | Target | Chain A, Structure Of Giardia Fructose-1,6-Biphosphate Aldolase In Complex With Phosphoglycolohydrox [gi:122920737] | | PubMed | | | Data Table |  |
|
| 29 | [SID49679332] | Inactive | | | Fluorescence-based counterscreen assay for HCV NS3 helicase inhibitors: biochemical high-throughput screening assay to identify compounds that cause fluorescent intercalator displacement (FID) [AID1845, Type: screening] | NS3 [Hepatitis C virus] [gi:125541954] |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 49679332 | | CID | 45105751 | | Outcome | Inactive | | BioAssay | Fluorescence-based counterscreen assay for HCV NS3 helicase inhibitors: biochemical high-throughput screening assay to identify compounds that cause fluorescent intercalator displacement (FID) | | AID | 1845 | | BioAssay type | screening | | Target | NS3 [Hepatitis C virus] [gi:125541954] | | PubMed | | | Data Table |  |
|
| 30 | [SID49679332] | Inactive | | | Fluorescence-based primary biochemical high throughput screening assay to identify inhibitors of the Hepatitis C Virus non-structural protein 3 helicase (NS3) [AID1800, Type: screening] | NS3 [Hepatitis C virus] [gi:125541954] |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 49679332 | | CID | 45105751 | | Outcome | Inactive | | BioAssay | Fluorescence-based primary biochemical high throughput screening assay to identify inhibitors of the Hepatitis C Virus non-structural protein 3 helicase (NS3) | | AID | 1800 | | BioAssay type | screening | | Target | NS3 [Hepatitis C virus] [gi:125541954] | | PubMed | | | Data Table |  |
|
| 31 | [SID49679332] | Inactive | | | C. difficile toxins: HTS for inhibitors of TcdB glycohydrolase activity Measured in Biochemical System Using Plate Reader - 7074-01_Inhibitor_SinglePoint_HTS_Activity [AID652162, Type: screening] | Toxin B [Clostridium difficile 630] [gi:126698238] |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 49679332 | | CID | 45105751 | | Outcome | Inactive | | BioAssay | C. difficile toxins: HTS for inhibitors of TcdB glycohydrolase activity Measured in Biochemical System Using Plate Reader - 7074-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 652162 | | BioAssay type | screening | | Target | Toxin B [Clostridium difficile 630] [gi:126698238] | | PubMed | | | Data Table |  |
|
| 32 | [SID49679332] | Inactive | | | uHTS identification of modulators of interaction between CendR and NRP-1 using Fluorescence Polarization assay [AID602438, Type: screening] | Chain A, Crystal Structure Of The B1b2 Domains From Human Neuropilin- 1 [gi:160877737] |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 49679332 | | CID | 45105751 | | Outcome | Inactive | | BioAssay | uHTS identification of modulators of interaction between CendR and NRP-1 using Fluorescence Polarization assay | | AID | 602438 | | BioAssay type | screening | | Target | Chain A, Crystal Structure Of The B1b2 Domains From Human Neuropilin- 1 [gi:160877737] | | PubMed | | | Data Table |  |
|
| 33 | [SID49679332] | Inactive | Potency | | qHTS Assay for Inhibitors of JMJD2A-Tudor Domain [AID504339, Type: confirmatory] | Chain A, Jmjd2a Tandem Tudor Domains In Complex With A Trimethylated Histone H4-K20 Peptide [gi:162330054] |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 49679332 | | CID | 45105751 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors of JMJD2A-Tudor Domain | | AID | 504339 | | BioAssay type | confirmatory | | Target | Chain A, Jmjd2a Tandem Tudor Domains In Complex With A Trimethylated Histone H4-K20 Peptide [gi:162330054] | | PubMed | | | Data Table |  |
|
| 34 | [SID49679332] | Inactive | | | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set [AID588497, Type: Literature] | botulinum neurotoxin type F, BoNT/F [Clostridium botulinum Bf] [gi:168184763] |   View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 49679332 | | CID | 45105751 | | Outcome | Inactive | | BioAssay | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set | | AID | 588497 | | BioAssay type | Literature | | Target | botulinum neurotoxin type F, BoNT/F [Clostridium botulinum Bf] [gi:168184763] | | PubMed | 16604538 | | Data Table |  |
|
| 35 | [SID49679332] | Inactive | Potency | | qHTS for Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in Human Glioma: qHTS [AID602332, Type: confirmatory] | heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) [Homo sapiens] [gi:168984549] |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 49679332 | | CID | 45105751 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in Human Glioma: qHTS | | AID | 602332 | | BioAssay type | confirmatory | | Target | heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) [Homo sapiens] [gi:168984549] | | PubMed | | | Data Table |  |
|
| 36 | [SID49679332] | Inactive | Potency | | qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a [AID504332, Type: confirmatory] | euchromatic histone-lysine N-methyltransferase 2 [Homo sapiens] [gi:168985070] |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 49679332 | | CID | 45105751 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a | | AID | 504332 | | BioAssay type | confirmatory | | Target | euchromatic histone-lysine N-methyltransferase 2 [Homo sapiens] [gi:168985070] | | PubMed | | | Data Table |  |
|
| 37 | [SID49679332] | Inactive | Potency | | qHTS Assay for Inhibitors of Influenza NS1 Protein Function [AID2326, Type: confirmatory] | nonstructural protein 1 [Influenza A virus (A/WSN/1933(H1N1))] [gi:194352380] |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 49679332 | | CID | 45105751 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors of Influenza NS1 Protein Function | | AID | 2326 | | BioAssay type | confirmatory | | Target | nonstructural protein 1 [Influenza A virus (A/WSN/1933(H1N1))] [gi:194352380] | | PubMed | | | Data Table |  |
|
| 38 | [SID49679332] | Inactive | IC50 | | Primary and Confirmatory Screening for Flavivirus Genomic Capping Enzyme Inhibition [AID588689, Type: confirmatory] | Chain A, Crystal Structure Of Dengue-2 Virus Methyltransferase Complexed With S-Adenosyl-L-Homocyste [gi:219689243] |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 49679332 | | CID | 45105751 | | Outcome | Inactive | | IC50 | [uM] | | BioAssay | Primary and Confirmatory Screening for Flavivirus Genomic Capping Enzyme Inhibition | | AID | 588689 | | BioAssay type | confirmatory | | Target | Chain A, Crystal Structure Of Dengue-2 Virus Methyltransferase Complexed With S-Adenosyl-L-Homocyste [gi:219689243] | | PubMed | | | Data Table |  |
|
| 39 | [SID49679332] | Inactive | IC50 | | Discovery of Small Molecule Probes for H1N1 Influenza NS1A [AID504329, Type: confirmatory] | nonstructural protein 1 [Influenza A virus (A/California/07/2009(H1N1))] [gi:227977143] |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 49679332 | | CID | 45105751 | | Outcome | Inactive | | IC50 | [uM] | | BioAssay | Discovery of Small Molecule Probes for H1N1 Influenza NS1A | | AID | 504329 | | BioAssay type | confirmatory | | Target | nonstructural protein 1 [Influenza A virus (A/California/07/2009(H1N1))] [gi:227977143] | | PubMed | | | Data Table |  |
|
| 40 | [SID49679332] | Inactive | Potency | | qHTS Assay for Identification of Novel General Anesthetics [AID485281, Type: confirmatory] | Chain A, Horse Spleen Apoferritin [gi:254220970] |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 49679332 | | CID | 45105751 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Identification of Novel General Anesthetics | | AID | 485281 | | BioAssay type | confirmatory | | Target | Chain A, Horse Spleen Apoferritin [gi:254220970] | | PubMed | | | Data Table |  |
|
| 41 | [SID49679332] | Inactive | Potency | | qHTS Assay for Inhibitors of Leishmania Mexicana Pyruvate Kinase (LmPK) [AID1721, Type: confirmatory] | pyruvate kinase [Leishmania mexicana mexicana] [gi:290753097] |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 49679332 | | CID | 45105751 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors of Leishmania Mexicana Pyruvate Kinase (LmPK) | | AID | 1721 | | BioAssay type | confirmatory | | Target | pyruvate kinase [Leishmania mexicana mexicana] [gi:290753097] | | PubMed | | | Data Table |  |
|
| 42 | [SID49679332] | Inactive | Potency | | qHTS Assay for Activators of Leishmania Mexicana Pyruvate Kinase (LmPK) [AID1722, Type: confirmatory] | pyruvate kinase [Leishmania mexicana mexicana] [gi:290753097] |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 49679332 | | CID | 45105751 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Activators of Leishmania Mexicana Pyruvate Kinase (LmPK) | | AID | 1722 | | BioAssay type | confirmatory | | Target | pyruvate kinase [Leishmania mexicana mexicana] [gi:290753097] | | PubMed | | | Data Table |  |
|
| 43 | [SID49679332] | Inactive | | | C-LANA FP assay Measured in Biochemical System Using Plate Reader - 2117-01_Inhibitor_SinglePoint_HTS_Activity [AID504423, Type: screening] | LANA [Human herpesvirus 8] [gi:312275222] |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 49679332 | | CID | 45105751 | | Outcome | Inactive | | BioAssay | C-LANA FP assay Measured in Biochemical System Using Plate Reader - 2117-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 504423 | | BioAssay type | screening | | Target | LANA [Human herpesvirus 8] [gi:312275222] | | PubMed | | | Data Table |  |
|
| 44 | [SID49679332] | Inactive | | | TRFRET-based biochemical primary high throughput screening assay to identify inhibitors of the interaction of the Ras and Rab interactor 1 protein (Rin1) and the c-abl oncogene 1, non-receptor tyrosine kinase (Abl) [AID588664, Type: screening] | ABL1 gene product [Homo sapiens] [gi:62362414] |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 49679332 | | CID | 45105751 | | Outcome | Inactive | | BioAssay | TRFRET-based biochemical primary high throughput screening assay to identify inhibitors of the interaction of the Ras and Rab interactor 1 protein (Rin1) and the c-abl oncogene 1, non-receptor tyrosine kinase (Abl) | | AID | 588664 | | BioAssay type | screening | | Target | ABL1 gene product [Homo sapiens] [gi:62362414] | | PubMed | | | Data Table |  |
|
| 45 | [SID49679332] | Inactive | | | TRFRET-based biochemical primary high throughput screening assay to identify inhibitors of the interaction of the Ras and Rab interactor 1 protein (Rin1) and the c-abl oncogene 1, non-receptor tyrosine kinase (Abl) [AID588664, Type: screening] | ABL1 gene product [Homo sapiens] [gi:62362414] |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 49679332 | | CID | 45105751 | | Outcome | Inactive | | BioAssay | TRFRET-based biochemical primary high throughput screening assay to identify inhibitors of the interaction of the Ras and Rab interactor 1 protein (Rin1) and the c-abl oncogene 1, non-receptor tyrosine kinase (Abl) | | AID | 588664 | | BioAssay type | screening | | Target | ABL1 gene product [Homo sapiens] [gi:62362414] | | PubMed | | | Data Table |  |
|
| 46 | [SID49679332] | Inactive | | | uHTS identification of small molecule inhibitors of Low Molecular Weight Protein Tyrosine Phosphatase, LMPTP, via a fluorescence intensity assay [AID651560, Type: screening] | Low molecular weight phosphotyrosine protein phosphatase [gi:1709543] |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 49679332 | | CID | 45105751 | | Outcome | Inactive | | BioAssay | uHTS identification of small molecule inhibitors of Low Molecular Weight Protein Tyrosine Phosphatase, LMPTP, via a fluorescence intensity assay | | AID | 651560 | | BioAssay type | screening | | Target | Low molecular weight phosphotyrosine protein phosphatase [gi:1709543] | | PubMed | | | Data Table |  |
|
| 47 | [SID49679332] | Inactive | | | uHTS identification of small molecule inhibitors of Low Molecular Weight Protein Tyrosine Phosphatase, LMPTP, via a fluorescence intensity assay [AID651560, Type: screening] | Low molecular weight phosphotyrosine protein phosphatase [gi:1709543] |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 49679332 | | CID | 45105751 | | Outcome | Inactive | | BioAssay | uHTS identification of small molecule inhibitors of Low Molecular Weight Protein Tyrosine Phosphatase, LMPTP, via a fluorescence intensity assay | | AID | 651560 | | BioAssay type | screening | | Target | Low molecular weight phosphotyrosine protein phosphatase [gi:1709543] | | PubMed | | | Data Table |  |
|
| 48 | [SID49679332] | Inactive | | | HTS for Beta-2AR agonists via FAP method [AID504454, Type: screening] | ADRB2 gene product [Homo sapiens] [gi:4501969] |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 49679332 | | CID | 45105751 | | Outcome | Inactive | | BioAssay | HTS for Beta-2AR agonists via FAP method | | AID | 504454 | | BioAssay type | screening | | Target | ADRB2 gene product [Homo sapiens] [gi:4501969] | | PubMed | | | Data Table |  |
|
| 49 | [SID49679332] | Inactive | | | HTS for Beta-2AR agonists via FAP method [AID504454, Type: screening] | ADRB2 gene product [Homo sapiens] [gi:4501969] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 49679332 | | CID | 45105751 | | Outcome | Inactive | | BioAssay | HTS for Beta-2AR agonists via FAP method | | AID | 504454 | | BioAssay type | screening | | Target | ADRB2 gene product [Homo sapiens] [gi:4501969] | | PubMed | | | Data Table |  |
|
| 50 | [SID49679332] | Inactive | | | HTS for Beta-2AR agonists via FAP method [AID504454, Type: screening] | ADRB2 gene product [Homo sapiens] [gi:4501969] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 49679332 | | CID | 45105751 | | Outcome | Inactive | | BioAssay | HTS for Beta-2AR agonists via FAP method | | AID | 504454 | | BioAssay type | screening | | Target | ADRB2 gene product [Homo sapiens] [gi:4501969] | | PubMed | | | Data Table |  |
|